Status epilepticus

Annals of Indian Academy of Neurology

Volumn 12, Issue 3, 2009, Pages 140-153

  Cherian, Ajith ^a   Thomas, Sanjeev V ^b  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Anticonvulsants; Barbiturates; Lorazepam; Midazolam; Phenytoin; Propofol; Refractory status epilepticus; Status epilepticus

Indexed keywords

AMFEBUTAMONE; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CEPHALOSPORIN; CHLORPROMAZINE; CIPROFLOXACIN; CLOZAPINE; DIPHENHYDRAMINE; ERYTHROMYCIN; ETIRACETAM; FENTANYL; FLUMAZENIL; FOSPHENYTOIN SODIUM; IMIPENEM; ISONIAZID; LORAZEPAM; MAPROTILINE; METRONIDAZOLE; MIDAZOLAM; NEUROLEPTIC AGENT; OFLOXACIN; PENICILLIN DERIVATIVE; PROPOFOL; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

ASSISTED VENTILATION; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; EEG ABNORMALITY; EPILEPTIC STATE; GABAERGIC SYSTEM; HEMODYNAMICS; HUMAN; MORBIDITY; MORTALITY; NEUROIMAGING; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SEIZURE; SIDE EFFECT; TACHYPHYLAXIS;

EID: 70350111174     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.56312     Document Type: Review

References (49)

1. Logroscino G, Hesdorffer DC, Cascino GD, Annegers JF, Bagiella E, Hauser WA. Long-term mortality after a first episode of status epilepticus. Neurology 2002;58:537-541
2. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995;12:316-325
3. Gastaut H. A propos d. une classification symptomatologique des etats de mal epileptiques. In: Gastaut H, Roger J, Lob H, editors. Les etats de mal epileptiques. Paris: Masson; 1967. p. 1-8.
4. Gastaut H. Clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1970;2:102-113
5. Brodie M. Status epilepticus in adults. Lancet 1990;336:551-552
6. Theodore WH, Porter RJ, Albert P, Kelley K, Bromfield E, Devinsky O, et al. The secondarily generalized tonic-clonic seizure: A videotape analysis. Neurology 1994;44:1403-1407
7. Towne A, Pellock J, Ko D, DeLorenzo R. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34.
8. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338:970-976
9. Shorvon S. Status epilepticus: Its clinical features and treatment in children and adults. Cambridge, England: Cambridge University Press; 1994. p. 201e.
10. Husain AM, Horn GJ, Jacobson MP. Non-convulsive status epilepticus: Usefulness of clinical features in selecting patients for urgent EEG. J Neurol Neurosurg Psychiatry 2003;74:189-191
11. Leis AA, Ross MA, Summers AK. Psychogenic seizures: Ictal characteristics and diagnostic pitfalls. Neurology 1992;42:95-99
12. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029-1035
13. Hauser WA. Status epilepticus: Epidemiologic considerations. Neurology 1990;40:9-13.
14. Ramsay RE, Pryor F. Epilepsy in the elderly. Neurology 2000;55:S9-14.
15. Chapman MG, Smith M, Hirsch NP. Status epilepticus. Anaesthesia 2001;56:648-659
16. Crawley J, Smith S, Kirkham F, Muthinji P, Waruiru C, Marsh K. Seizures and status epilepticus in childhood cerebral malaria. Q J Med 1996;89:591-597
17. Misra UK, Kalita J, Nair PP .Status epilepticus in central nervous system infections: An experience from a developing country. Am J Med 2008;121:618-623
18. DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults, and the elderly. Epilepsia 1992;33:S15-25.
19. Pal S, Sombati S, Limbrick DD Jr, DeLorenzo RJ. In vitro status epilepticus causes sustained elevation of intracellular calcium levels in hippocampal neurons. Brain Res 1999;851:20-31.
20. Bleck TP. Refractory status epilepticus in 2001. Arch Neurol 2002;59:188-189
21. Kapur J, Stringer JL, Lothman EW. Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition. J Neurophysiol 1989;61:417-426
22. Kapur J, Lothman EW. Loss of inhibition precedes delayed spontaneous seizures in the hippocampus after tetanic electrical stimulation. J Neurophysiol 1989;61:427-434
23. Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci 1997;17:7532-7540
24. Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates: Ischemic cell change and its relation to ictal physiological events. Arch Neurol 1973;28:10-17
25. Nevander G, Ingvar M, Auer R, Siesjö BK. Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol 1985;18:281-290
26. Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993;34:S37-53.
27. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990;5:49-60.
28. Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology 2003;40:13-23.
29. Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR Jr, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000;54:340-345
30. Coplin WM, Pierson DJ, Cooley KD, Newell DW, Rubenfeld GD. Implications of extubation delay in brain-injured patients meeting standard weaning criteria. Am J Respir Crit Care Med 2000;161:1530-1536
31. Marshall RJ, Muir AW, Sleigh T, Savage DS. An overview of the pharmacology of rocuronium bromide in experimental animals. Eur J Anaesthesiol Suppl 1994;9:9-15.
32. Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia 1999;40:S59-63.
33. Riviello JJ Jr, Ashwal S, Hirtz D, Glauser T, Ballaban-Gil K, Kelley K, et al. Practice parameter: Diagnostic assessment of the child with status epilepticus (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2006;67:1542-1550 (Pubitemid 44747921)
34. Modified from Shih T, Bazil CW Treatment of generalized convulsive status epilepticus from Dislane FW (Ed) Current clinical neurology Status epilepticus: A clinical perspectiveHumana Press Totowa NJ, USA 2005:265-288
35. Treiman DM, Meyers PD, Walton NY. A comparison of four treatments for generalized convulsive status epilepticus: Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792-798
36. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345:631-637
37. Sorel L, Mechler L, Harmant J. Comparative trial of intravenous lorazepam and clonazepam in status epilepticus. Clin Ther 1981;4:326-336
38. Gottwald MD, Akers LC, Liu PK, Orsulak PJ, Corry MD, Bacchetti P, et al. Prehospital stability of diazepam and lorazepam. Am J Emerg Med 1999;17:333-337
39. DeLorenzo RJ, Waterhouse EJ, Towne AR, Boggs JG, Ko D, DeLorenzo GA, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998;39:833-840
40. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: A pilot study. Neurology 2006;67:340-342
41. Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, et al. Levetiracetam intravenous infusion: A randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 2006;47:1128-1135
42. Perry MS, Holt RJ, Sladky JT. Topiramate loading for refractory status epilepticus. Epilepsia 2006;47:1070-1071
43. Indian Epilepsy Society. Indian Guidelines for the Management of Epilepsy: GEMIND. Available from: http://www.epilepsyindia.org/gemind-main.asp. [cited in 2008].
44. Hara M, Kai Y, Ikemoto Y. Propofol activates GABAA receptor- chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 1993;79:781-788
45. Stecker MM, Kramer TH, Raps EC, O'Meeghan R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings. Epilepsia 1998;39:18-26.
46. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: A simple name for a complex syndrome. Intensive Care Med 2003;29:1417-1425
47. Kang TM. Propofol infusion syndrome in critically ill patients. Ann Pharmacother 2002;36:1453-1456
48. Parke TJ, Stevens JE, Rice AS, Greenaway CL, Bray RJ, Smith PJ, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: Five case reports. BMJ 1992;305:613-616
49. Naritoku DK, Sinha S. Prolongation of midazolam half-life after sustained infusion for status epilepticus. Neurology 2000;54:1366-1368